4.3 Article

Healthcare utilization and costs of atopic dermatitis in Taiwan

Journal

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
Volume 121, Issue 10, Pages 1963-1971

Publisher

ELSEVIER TAIWAN
DOI: 10.1016/j.jfma.2022.01.028

Keywords

Atopic dermatitis; Healthcare utilization; Cost of illness; National health insurance; Economic burden

Ask authors/readers for more resources

This study aimed to evaluate the annual healthcare utilization and costs associated with atopic dermatitis (AD) in Taiwan. The study found that outpatient visits increased with the severity of AD, while there was no consistent pattern in inpatient care and emergency room visits. AD imposes a significant burden of healthcare costs and accounts for a small percentage of Taiwan's national health expenditure and gross domestic product.
Background: Atopic dermatitis (AD) is a common chronic skin disease. Only relatively scant studies from Asian countries have attempted to quantify AD-associated healthcare utilization and costs by using population-based databases. This study aims to evaluate the AD-associated annual healthcare utilization and costs in Taiwan. Methods: A retrospective matched-cohort study was conducted by matching the AD cases with controls at a 1:4 (cases:controls) ratio, with the data for both the cases and controls being sourced from the 2017 National Health Insurance Research Database (NHIRD). The AD patients were stratified by disease severity based on their treatments. Differences in the regression-adjusted frequency of care and costs between the cases and controls were compared using t-tests by the severity level of AD.Results: The incremental frequency of outpatient visits per year increased with AD severity (9.60, 11.28, and 16.23 for mild, moderate, and severe cases, respectively). However, the fre-quency of inpatient care and emergency room visits per year showed no consistent pattern associated with disease severity. The incremental total costs per year were NT$9,511.64, NT$9,705.20, and NT$15,762.09 for mild, moderate, and severe cases, respectively, and the outpatient and drug costs accounted for 46.65%-54.82% and 17.01%-31.20% of the total costs, respectively.Conclusion: AD was found to impose significant healthcare costs, with estimated total cost bur-dens of NT$3.61 billion in 2017, which is 0.314% of Taiwan's national health expenditure and 0.020% of Taiwan's gross domestic product.Copyright 2022, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available